Core Scientific Inc (CORZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,049,464 | -594,205 | 210,691 | -246,487 | -50,794 |
| Depreciation Amortization | 93,328 | 62,350 | 30,426 | 97,197 | 65,503 |
| Accounts receivable | N/A | N/A | -106 | -744 | -852 |
| Accounts payable and accrued liabilities | -11,640 | -11,480 | -9,735 | 118,911 | 32,771 |
| Other Working Capital | -51,919 | -50,458 | -19,359 | 571,668 | 285,567 |
| Other Operating Activity | 1,048,786 | 617,171 | -189,743 | -475,431 | -288,784 |
| Operating Cash Flow | $29,091 | $23,378 | $22,174 | $65,114 | $43,411 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66,203 | -35,029 | -31,894 | -16,161 | -4,516 |
| Net Acquisitions | N/A | N/A | N/A | 13,998 | N/A |
| Purchase Sale Intangibles | -191 | -125 | -76 | -833 | -840 |
| Other Investing Activity | -191 | -125 | -76 | -833 | -840 |
| Investing Cash Flow | $-66,394 | $-35,154 | $-31,970 | $-2,996 | $-5,356 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 447,609 | N/A | N/A | N/A | N/A |
| Debt Repayment | -299,745 | -32,814 | -17,256 | -44,649 | -26,352 |
| Common Stock Issued | 56,922 | 55,376 | 55,009 | N/A | N/A |
| Other Financing Activity | 16,610 | 16,610 | 16,610 | 0 | 0 |
| Financing Cash Flow | $221,396 | $39,172 | $54,363 | $-44,649 | $-26,352 |
| Beginning Cash Position | 69,709 | 69,709 | 69,709 | 52,240 | 52,240 |
| End Cash Position | 253,802 | 97,105 | 114,276 | 69,709 | 63,943 |
| Net Cash Flow | $184,093 | $27,396 | $44,567 | $17,469 | $11,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,091 | 23,378 | 22,174 | 65,114 | 43,411 |
| Capital Expenditure | -66,203 | -35,029 | -31,894 | -16,161 | -4,516 |
| Free Cash Flow | -37,112 | -11,651 | -9,720 | 48,953 | 38,895 |